OXiGENE (OXGN) Names Matthew M. Loar as CFO
Tweet Send to a Friend
OXiGENE, Inc. (Nasdaq: OXGN), a biopharmaceutical company developing novel therapies for treatment of cancer, today announced that Matthew M. Loar ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE